Literature DB >> 2561877

Image localized 31P magnetic resonance spectroscopy of the human liver.

G M Glazer1, S R Smith, T L Chenevert, P A Martin, A N Stevens, R H Edwards.   

Abstract

Image localized 31P magnetic resonance (MR) spectroscopy of the liver was performed in twelve normal volunteers and seven patients with hepatic tumours. The tumours which were clearly imaged by proton MR could also be distinguished from normal tissue because of spectral differences. The malignant tumours had significantly elevated phosphomonoester/inorganic phosphate and phosphomonoester/beta-adenosine triphosphate ratios, probably due to elevated tumour concentrations of phosphocholine and phosphoethanolamine, which are intermediates in the synthesis of membrane phospholipids. The pH values of the malignant tumours were elevated compared to normal hepatic parenchyma. Liver spectra in two patients with the commonest benign hepatic neoplasm, cavernous haemangioma, differed from both normal tissue and the malignant tumours in having a very low signal/noise ratio but apparently normal relative levels of phosphomonoester.

Entities:  

Mesh:

Year:  1989        PMID: 2561877     DOI: 10.1002/nbm.1940010406

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  3 in total

1.  Influence of different fasting periods on P-31-MR-spectroscopy of the liver in normals and patients with liver metastases.

Authors:  G Brinkmann; U H Melchert; C Muhle; J Brossmann; J Link; M Reuter; M Heller
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy.

Authors:  R M Dixon; P W Angus; B Rajagopalan; G K Radda
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

3.  The assessment of treatment response in non-Hodgkin's lymphoma by image guided 31P magnetic resonance spectroscopy.

Authors:  S R Smith; P A Martin; J M Davies; R H Edwards; A N Stevens
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.